Turnover
The micro format states no turnover.
The micro format states no turnover.
Higher net result than 89% of companies in human health. The sector median is €59,520, over 21,372 companies.
In July 2024, 144 companies had the same profile as BSRX has now. Each dot is one company, two years later.
The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.4% | 0.5% |
| 3 | 0.6% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.4% | 1.6% |
| 7 | 1.7% | 1.8% |
| 8 | 1.9% | 2.0% |
| 9 | 3.1% | 3.3% |
| 10 | 5.9% | 6.4% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 144 companies, not a prediction for BSRX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
| Company | ||||
|---|---|---|---|---|
| BSRX Ghent | €487,545 | €315,728 | 43.4% | - |
| OOGARTSEN PARK SINT-TRUIDEN Sint-Truiden | €472,548 | €337,160 | 2.1% | 3.3 |
| E.J. MEDICAL Ninove | €406,163 | €334,664 | 46.9% | - |
| DerMMato Ghent | €388,680 | €270,250 | 35.0% | - |
| PJRJ Uccle | €437,797 | €354,519 | 51.8% | - |
| SCANRE Turnhout | €536,134 | €281,557 | 75.6% | - |
| Aeranes Pajottegem | €493,475 | €377,553 | 76.2% | - |
These companies have the same main activity as BSRX: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €389,000 and €536,000, founded between 2024 and 2025.
BSRX has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €211,819 and a net result of €206,819.
Its solvency ranks better than 34% of 21,385 sector peers (NACE 86) in financial year 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.